FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016012287> ?p ?o ?g. }

• W2016012287 endingPage "1808" @default.
• W2016012287 startingPage "1803" @default.
• W2016012287 abstract "BACKGROUND The effect of p53 protein expression and MIB-1 proliferative activity on survival and chemotherapeutic response in patients with lymph node (LN)-positive transitional cell carcinoma (TCC) of the urinary bladder remains unclear. The objective of this study was to assess the ability of these markers to predict disease-associated outcomes and response to chemotherapy in a cohort of patients with LN-positive TCC. METHODS The authors examined the expression of p53 and MIB-1 in the LN metastases from 139 patients who underwent cystectomy for TCC at their institution. P53 and MIB-1 nuclear staining were quantified using an image-analysis system. Cox proportional hazards regression models were used to test associations of these markers with death from TCC, distant metastases, and local recurrence for all patients and in the subset of patients who were treated with adjuvant chemotherapy. RESULTS The median p53 and MIB-1 indices were 45.2% and 30.3%, respectively. The median follow-up was 4.5 years (range, 0.1–10 years). There were no statistically significant associations noted between the p53 and MIB-1 indices and the outcomes studied. When the analysis was limited to patients who were treated with adjuvant chemotherapy (n = 37 patients), the p53 index was found to have no prognostic value; however, there was a significant association between MIB-1 and distant metastases (P = 0.049). When disease-specific survival rates were stratified according to p53 index and chemotherapy, patients exhibited a response to chemotherapy regardless of p53 index. CONCLUSIONS p53 and MIB-1 were not found to be associated significantly with disease-related outcomes in patients with LN-positive TCC. Adjuvant chemotherapy appeared to be effective regardless of p53 status. MIB-1 may prove useful in predicting response to chemotherapy. Cancer 2004. © 2004 American Cancer Society." @default.
• W2016012287 created "2016-06-24" @default.
• W2016012287 creator A5010282758 @default.
• W2016012287 creator A5013581522 @default.
• W2016012287 creator A5019283638 @default.
• W2016012287 creator A5054026884 @default.
• W2016012287 creator A5065393937 @default.
• W2016012287 creator A5066721028 @default.
• W2016012287 creator A5067282152 @default.
• W2016012287 creator A5070253773 @default.
• W2016012287 creator A5082725102 @default.
• W2016012287 date "2004-10-15" @default.
• W2016012287 modified "2023-10-17" @default.
• W2016012287 title "Prognostic value of p53 and MIB-1 in transitional cell carcinoma of the urinary bladder with regional lymph node involvement" @default.
• W2016012287 cites W1505402845 @default.
• W2016012287 cites W1543003185 @default.
• W2016012287 cites W1625884577 @default.
• W2016012287 cites W1820014750 @default.
• W2016012287 cites W1941332786 @default.
• W2016012287 cites W1973645342 @default.
• W2016012287 cites W1979319210 @default.
• W2016012287 cites W1985636678 @default.
• W2016012287 cites W2001453283 @default.
• W2016012287 cites W2018205075 @default.
• W2016012287 cites W2018823883 @default.
• W2016012287 cites W2024613014 @default.
• W2016012287 cites W2032206932 @default.
• W2016012287 cites W2042412509 @default.
• W2016012287 cites W2053822654 @default.
• W2016012287 cites W2053888035 @default.
• W2016012287 cites W2057998930 @default.
• W2016012287 cites W2060655552 @default.
• W2016012287 cites W2076767972 @default.
• W2016012287 cites W2079777245 @default.
• W2016012287 cites W2095114387 @default.
• W2016012287 cites W2114473143 @default.
• W2016012287 cites W2127066238 @default.
• W2016012287 cites W2139519504 @default.
• W2016012287 cites W2318856916 @default.
• W2016012287 cites W2410257367 @default.
• W2016012287 doi "https://doi.org/10.1002/cncr.20567" @default.
• W2016012287 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15386300" @default.
• W2016012287 hasPublicationYear "2004" @default.
• W2016012287 type Work @default.
• W2016012287 sameAs 2016012287 @default.
• W2016012287 citedByCount "23" @default.
• W2016012287 countsByYear W20160122872012 @default.
• W2016012287 countsByYear W20160122872013 @default.
• W2016012287 countsByYear W20160122872015 @default.
• W2016012287 countsByYear W20160122872016 @default.
• W2016012287 countsByYear W20160122872017 @default.
• W2016012287 countsByYear W20160122872021 @default.
• W2016012287 countsByYear W20160122872023 @default.
• W2016012287 crossrefType "journal-article" @default.
• W2016012287 hasAuthorship W2016012287A5010282758 @default.
• W2016012287 hasAuthorship W2016012287A5013581522 @default.
• W2016012287 hasAuthorship W2016012287A5019283638 @default.
• W2016012287 hasAuthorship W2016012287A5054026884 @default.
• W2016012287 hasAuthorship W2016012287A5065393937 @default.
• W2016012287 hasAuthorship W2016012287A5066721028 @default.
• W2016012287 hasAuthorship W2016012287A5067282152 @default.
• W2016012287 hasAuthorship W2016012287A5070253773 @default.
• W2016012287 hasAuthorship W2016012287A5082725102 @default.
• W2016012287 hasBestOaLocation W20160122871 @default.
• W2016012287 hasConcept C121608353 @default.
• W2016012287 hasConcept C126322002 @default.
• W2016012287 hasConcept C126894567 @default.
• W2016012287 hasConcept C142724271 @default.
• W2016012287 hasConcept C143998085 @default.
• W2016012287 hasConcept C146357865 @default.
• W2016012287 hasConcept C151730666 @default.
• W2016012287 hasConcept C2775910329 @default.
• W2016012287 hasConcept C2776694085 @default.
• W2016012287 hasConcept C2777546739 @default.
• W2016012287 hasConcept C2778065480 @default.
• W2016012287 hasConcept C2779762690 @default.
• W2016012287 hasConcept C2780352672 @default.
• W2016012287 hasConcept C2780849966 @default.
• W2016012287 hasConcept C50382708 @default.
• W2016012287 hasConcept C71924100 @default.
• W2016012287 hasConcept C72563966 @default.
• W2016012287 hasConcept C86803240 @default.
• W2016012287 hasConceptScore W2016012287C121608353 @default.
• W2016012287 hasConceptScore W2016012287C126322002 @default.
• W2016012287 hasConceptScore W2016012287C126894567 @default.
• W2016012287 hasConceptScore W2016012287C142724271 @default.
• W2016012287 hasConceptScore W2016012287C143998085 @default.
• W2016012287 hasConceptScore W2016012287C146357865 @default.
• W2016012287 hasConceptScore W2016012287C151730666 @default.
• W2016012287 hasConceptScore W2016012287C2775910329 @default.
• W2016012287 hasConceptScore W2016012287C2776694085 @default.
• W2016012287 hasConceptScore W2016012287C2777546739 @default.
• W2016012287 hasConceptScore W2016012287C2778065480 @default.
• W2016012287 hasConceptScore W2016012287C2779762690 @default.
• W2016012287 hasConceptScore W2016012287C2780352672 @default.
• W2016012287 hasConceptScore W2016012287C2780849966 @default.
• W2016012287 hasConceptScore W2016012287C50382708 @default.
• W2016012287 hasConceptScore W2016012287C71924100 @default.

• next